Phase 1/2 Study of Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Conditions: Sarcoma, Ewing; Rhabdomyosarcoma Interventions: Drug: PEN-866; Drug: Vincristine; Drug: Temozolomide Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Cancers | Cancer & Oncology | Cancer in Adolescents | Cancer in Young Adults | Research | Rhabdomyosarcoma | Sarcomas | Study | Temodar